insights_auto
Outlook: 83.3% bullish·0.0% bearish
Go to analysischevron_right
M1RN34:BVMF
Moderna Inc Bdr
R$68,80
0,00%
(0,00) 1D
11 Nov., 18:08:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
R$70,93
High
R$70,96
Low
R$67,64
Mkt. cap
100,63 mjd
Avg. vol.
169,75 k
Volume
155,86 k
52-wk high
R$77,25
52-wk low
R$6,02
Shares outstanding
404,62 m
No. of employees
5 k
Open
R$70,93
High
R$70,96
Low
R$67,64
Mkt. cap
100,63 mjd
Avg. vol.
169,75 k
Volume
155,86 k
52-wk high
R$77,25
52-wk low
R$6,02
Shares outstanding
404,62 m
No. of employees
5 k
News stories
From web sources and news partners
TradingKey
·
1 dag gelede
Moderna Inc Stock (MRNA) Moved Down by 4.50% on Nov 10: Drivers Behind the Movement
Financial Times
·
1 dag gelede
Moderna chasing ‘holy grail’ of cancer prevention
StreetInsider
·
1 dag gelede
Moderna shares decline after hitting 52-week high
Yahoo Finance
·
1 dag gelede
Why is Moderna (MRNA) stock soaring today
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr
CEOStéphane Bancel
Employees4,7 k
FoundedSep. 2010
Headquarters-
SectorHealth Care
Industry-
Websitemodernatx.com